CD4 and neoplasm: Strategies that enhance the polyfunctional effector profiles of CD4+ T cells may therefore improve the efficacy of CAR therapy, particularly as it has been established that CAR-engrafted CD4+ T cells play a crucial role in tumour eradication [2].